Moreover, adducin is phosphorylated by PKC at elevated levels in renal carcinomas, and this aberrant phosphorylation correlates with changes in adducin subcellular distribution (Fowler et al., 1998). The gene discussed is PRRT2; the disease is renal carcinoma.